Search Results
You are looking at 1 - 9 of 9 items for
- Author: A M Carter x
- Refine by access: All content x
Search for other papers by S. A. Whitehead in
Google Scholar
PubMed
Search for other papers by J. M. Pennington in
Google Scholar
PubMed
Search for other papers by D. A. Carter in
Google Scholar
PubMed
Changes in pituitary responses to pulses of LH releasing hormone (LH-RH) after ovariectomy in the rat have been investigated with an in-vitro perifusion system. On the third day after ovariectomy there was a large increase in the responsiveness of the pituitary gland to LH-RH compared with days 1 and 2 and this preceded the first significant rise in circulating concentrations of LH. Exaggerated responses were observed on all subsequent days tested (days 4, 6, 10, 18 and 28) although the size of the response on day 10 was significantly lower compared with days 6, 18 or 28. It is suggested that the early phase of increased pituitary responsiveness to LH-RH results from a rise in pituitary LH-RH receptors, which increases both the synthesis of LH and the response to exogenous LH-RH. The reduced LH response, measured on day 10, may correlate with an increase in the endogenous secretion of LH-RH and an imbalance between LH synthesis and secretion at this time.
Search for other papers by D. A. Carter in
Google Scholar
PubMed
Search for other papers by T. D. M. Williams in
Google Scholar
PubMed
Search for other papers by S. L. Lightman in
Google Scholar
PubMed
ABSTRACT
The influence of endogenous opioids on the posterior pituitary response to stress was investigated by measuring plasma hormone levels in immobilized male and female rats following either acute naloxone treatment or prolonged morphine administration. Naloxone significantly potentiated the oxytocin and arginine vasopressin (AVP) response to immobilization, but in female rats only. The responses of morphine-treated male rats showed differences compared with vehicle-treated controls, although chronic morphine treatment did not reliably alter the oxytocin or AVP responses to immobilization in males or females.
In a further experiment to investigate the role of gonadal hormones in determining the sex difference in responsiveness to naloxone, it was found that acute naloxone treatment significantly potentiated the posterior pituitary response to stress in castrated male rats.
These results extend previous studies showing a sex difference in stress-induced secretion of posterior pituitary hormones, providing evidence of a sexual dimorphism in the endogenous opioid regulation of this response which is partly determined by circulating gonadal hormones.
J. Endocr. (1986) 111, 239–244
Search for other papers by A M Carter in
Google Scholar
PubMed
Search for other papers by J R G Challis in
Google Scholar
PubMed
Search for other papers by P Svendsen in
Google Scholar
PubMed
Abstract
To ascertain whether repeated hypoxic stress would alter the response of the adrenal cortex to adrenocorticotropic hormone (ACTH), by premature activation of the hypothalamic–pituitary–adrenal axis, we studied fetal sheep subjected to daily reduction of arterial oxygen content by embolization of the fetal placental circulation with 15 μm microspheres for 8 days from about day 124 of gestation (term ∼147 days) and sham-embolized controls. Starting before the final embolization (or shamembolization) on day 8, and continuing for 24 h, the fetus was given an intravenous infusion of ACTH1–24 (0·5 μg/h) or vehicle. Fetal and maternal blood samples were taken for determination of immunoreactive cortisol, and regional adrenal and fetal placental blood flows were measured by the microsphere technique at three time points: 1 h before infusion, 3 h after the start of the infusion (1 h after embolization), and after 24 h of infusion. Prior to infusion of ACTH or vehicle, fetal placental blood flow was lower in microsphere-embolized fetuses than in sham-embolized controls (199 ± 15 vs 292 ± 25 ml/min per 100 g tissue; mean ± s.e.; P<0·01). However, plasma cortisol and adrenal cortical blood flow did not differ between embolized fetuses and controls. Adrenal vascular responses to the 24-h infusion of ACTH were similar in embolized and shamembolized fetuses. Adrenal cortical blood flow increased 3-fold (P<0·05) due to decreased vascular resistance (P<0·01), with no change in adrenal medullary blood flow. Thus, while daily embolization of the fetal placental circulation caused a sustained decrease in cotyledonary blood flow, no evidence of altered responsiveness of the adrenal cortex to ACTH was found in these experiments.
Journal of Endocrinology (1996) 148, 517–522
Search for other papers by C. J. M. Poole in
Google Scholar
PubMed
Search for other papers by D. A. Carter in
Google Scholar
PubMed
Search for other papers by M. Vallejo in
Google Scholar
PubMed
Search for other papers by S. L. Lightman in
Google Scholar
PubMed
ABSTRACT
The effect of an atrial natriuretic peptide on the secretion of the neurohypophysial peptides arginine vasopressin (AVP) and oxytocin has been studied in vivo and in vitro. Atriopeptin III was administered intracerebroventricularly to conscious rats and plasma concentrations of AVP and oxytocin were determined both in controls and in rats which had their drinking water replaced by 2% NaCl. The release of both AVP and oxytocin was inhibited when basal levels were increased by the saline treatment. The inhibition of AVP release lasted for 40 min whereas oxytocin release was inhibited for 10 min only. In a further experiment the stimulated release of AVP and oxytocin from the isolated neurointermediate lobe of the rat was also inhibited by atriopeptin III.
J. Endocr. (1987) 112, 97–102
Search for other papers by S. J. CARTER in
Google Scholar
PubMed
Search for other papers by C. A. LAUD in
Google Scholar
PubMed
Search for other papers by I. SMITH in
Google Scholar
PubMed
Search for other papers by R. M. LEONE in
Google Scholar
PubMed
Search for other papers by R. J. L. HOOPER in
Google Scholar
PubMed
Search for other papers by R. E. SILMAN in
Google Scholar
PubMed
Search for other papers by M. D. A. FINNIE in
Google Scholar
PubMed
Search for other papers by P. E. MULLEN in
Google Scholar
PubMed
Search for other papers by D. L. LARSON-CARTER in
Google Scholar
PubMed
SUMMARY
5-Methoxytryptophol, a serotonin metabolite, was measured by gas chromatography–mass spectrometry in pineal glands, plasma and control tissues (cerebral cortex and salivary glands) from male rats kept in a controlled lighting environment. In the pineal gland the level of 5-methoxytryptophol was significantly higher during the dark period than during the light, the absolute levels being an order of magnitude less than those of melatonin. In the plasma, the levels showed a reverse situation with respect to lighting conditions. No correlation was found between the 5-methoxytryptophol levels in plasma and the pineal gland in individual animals. These results suggest that there is no obvious correlation between pineal content and pineal activity. This may be due to a combination of rapid turnover, secretion and/or peripheral conversion of another 5-methoxyindole to 5-methoxytryptophol.
Search for other papers by A M Carter in
Google Scholar
PubMed
Search for other papers by M J Kingston in
Google Scholar
PubMed
Search for other papers by K K Han in
Google Scholar
PubMed
Search for other papers by D M Mazzuca in
Google Scholar
PubMed
Search for other papers by K Nygard in
Google Scholar
PubMed
Search for other papers by V K M Han in
Google Scholar
PubMed
The IGF system is one of the most important endocrine and paracrine growth factor systems that regulate fetal and placental growth. We hypothesized that intrauterine growth restriction (IUGR) in guinea pigs is mediated by the altered expression of IGFs and/or IGF binding protein (BP) mRNAs in tissues and is related to growth of specific tissues. IUGR was induced by unilateral uterine artery ligation on day 30 of gestation, and fetal plasma, amniotic fluid and tissue samples were collected at 55–57 days (term about 68 days) from paired IUGR and control fetuses (n=6). Western ligand blotting and immunoblotting were used to compare IGFBP levels in plasma and amniotic fluid. Total RNA was extracted from placenta and fetal tissues, and the relative abundance of IGF-II and IGFBP-1–6 mRNA was determined by Northern blotting, using species-specific probes where available. IUGR fetuses had decreased (P<0.01, by Student’s t-test) placental weight and body weight with an increase in the brain:liver weight ratio. The principal IGFBPs in fetal plasma migrated at 40–35, 30 and 25 kDa and were identified as IGFBP-3, -2 and -4 respectively. IUGR was associated with elevated plasma IGFBP-2 and IGFBP-4 and reduced IGFBP-3 levels. IGFBPs were detected at low levels in amniotic fluid of control fetuses but at higher levels in IUGR fetuses. In IUGR placentae, there was a small increase in IGFBP-4 mRNA (P<0.05). IGFBP-2 mRNA increased (P<0.001) in liver of IUGR fetuses. IGF-II and IGFBP mRNA expression did not change in fetal muscle. The results are consistent with reduced IGF action, directly or through inhibition by IGFBPs, particularly by circulating and tissue IGFBP-2, as a potential causal factor in decreased growth of the placenta and certain fetal tissues.
Search for other papers by R. J. L. HOOPER in
Google Scholar
PubMed
Search for other papers by R. E. SILMAN in
Google Scholar
PubMed
Search for other papers by R. M. LEONE in
Google Scholar
PubMed
Search for other papers by M. D. A. FINNIE in
Google Scholar
PubMed
Search for other papers by S. J. CARTER in
Google Scholar
PubMed
Search for other papers by M. SAVAGE in
Google Scholar
PubMed
Search for other papers by M. PREECE in
Google Scholar
PubMed
Search for other papers by I. SMITH in
Google Scholar
PubMed
Search for other papers by P. E. MULLEN in
Google Scholar
PubMed
Pineal indoles have been shown to affect the release of anterior pituitary hormones but details of the interrelationships are lacking. Using a new gas chromatography–mass spectrometry (g.c.–m.s.) assay the concentration of 5-methoxytryptophol (ML) was measured in plasma samples obtained from 16 children undergoing investigation of pituitary function for delayed growth. All the children received an insulin tolerance test (ITT) to study their endocrine response to stress. Some children received luteinizing hormone releasing hormone (LH-RH) and/or thyrotrophin releasing hormone (TRH). The change in concentration of ML during an ITT was similar to the change in concentration of blood sugar; a drop at 20 min followed by a rise at 30 min. This was not significantly altered by the administration of LH-RH or TRH, nor was there a different pattern of response in children who were deficient in growth hormone as opposed to those with idiopathic delayed growth. The fall in concentration of ML with stress may mediate the increased secretion of pituitary hormones. Alternatively, the pineal gland may respond directly to insulin.
Search for other papers by R. M. LEONE in
Google Scholar
PubMed
Search for other papers by R. E. SILMAN in
Google Scholar
PubMed
Search for other papers by R. J. L. HOOPER in
Google Scholar
PubMed
Search for other papers by M. D. A. FINNIE in
Google Scholar
PubMed
Search for other papers by S. J. CARTER in
Google Scholar
PubMed
Search for other papers by R. EDWARDS in
Google Scholar
PubMed
Search for other papers by I. SMITH in
Google Scholar
PubMed
Search for other papers by P. TOWELL in
Google Scholar
PubMed
Search for other papers by P. E. MULLEN in
Google Scholar
PubMed
SUMMARY
5-Methoxytryptophol (ML) is found in the pineal gland and is known to have biological activity especially as an antigonadotrophic agent, but methods have been lacking for its measurement in the circulation. A gas chromatography–mass spectrometry assay using a trimethylsilyl derivative has been developed for the routine measurement of ML in plasma. The assay is of great specificity and has a sensitivity of 20 pmol/l. Studies on the levels of pineal indoles in the circulation, however, have been hampered by the possibility that extraneous compounds are being cross-measured. Thus the specificity of the routine assay has been further validated by comparing it with an alternative assay system where all the major parameters were changed, i.e. derivatizing reagent, internal standard and mass number. Results that were obtained using both assay systems were closely comparable.
Search for other papers by R. J. L. HOOPER in
Google Scholar
PubMed
Search for other papers by R. E. SILMAN in
Google Scholar
PubMed
Search for other papers by R. M. LEONE in
Google Scholar
PubMed
Search for other papers by M. D. A. FINNIE in
Google Scholar
PubMed
Search for other papers by S. J. CARTER in
Google Scholar
PubMed
Search for other papers by J. G. GRUDZINSKAS in
Google Scholar
PubMed
Search for other papers by Y. B. GORDON in
Google Scholar
PubMed
Search for other papers by DIANE T. HOLLAND in
Google Scholar
PubMed
Search for other papers by T. CHARD in
Google Scholar
PubMed
Search for other papers by P. E. MULLEN in
Google Scholar
PubMed
Search for other papers by I. SMITH in
Google Scholar
PubMed
SUMMARY
The pineal indole 5-methoxytryptophol (ML) has been shown to have an antigonadal activity when administered to experimental animals, but data on its normal pattern of secretion have been lacking. Using a new gas chromatography–mass spectrometry assay, the concentration of ML at various phases of the human menstrual cycle has been studied. Daily samples were obtained throughout the month from five women with a normal cycle and two women taking an oral contraceptive. In women with a normal cycle levels of ML were found to be significantly lower in the last third of their cycle; this change was not seen in women taking an oral contraceptive who had low levels throughout the month. The changes in concentration of ML did not correlate with the changes in concentration of gonadotrophins.
